- 14/05/2020 - 30/08/2020
- Carlos Chaccour
- Funded by
- ISGlobal, Clinica Universidad de Navarra, IDIFARMA
Ivermectin is a widely used drug for the treatment and control of certain neglected tropical diseases. The drug has an excellent safety profile, with more than 2.5 billion doses distributed in the last 30 years. It has proven activity against SARS-CoV-2 in vitro.
For this pilot trial we propose to test the potential of ivermectin to reduce the transmission of the virus. If the results are positive this could be quickly scaled given the known safety profile and robust drug supply.
Help Us Do Research on COVID-19!
If you suspect you might have COVID-19, and:
- you have symptoms compatible with the disease within the last 48 hours, such as fever, dry cough, headache, and general malaise;
- you are between 18 and 59 years old; and
- you live in the Pamplona Basin.
Please, call to the telephone number 628 659 003. In case you are a potential candidate, we will lead you to the ER of the Clínica Universidad de Navarra for a formal visit.
We will stop the new coronavirus together!
A Project by:
- Carlos Javier Chaccour
Other projectsSee Past Projects
Combating Bacterial Resistance In Europe
Application to medical devices
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
Integrating and decentralizing diabetes and hypertension services in Africa
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
Cendea de Cizur
Conèixer la propagació. Entendre la protecció
A breakthrough device for the rapid detection of antimicrobial resistance
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Hepatitis B Virus COMmunity Screening and Vaccination in Africans
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
Close the Gap, Increase Access, Provide Adequate Therapy
Strengthening Epidemiological Surveillance in Benin and Burkina Faso for an Effective Response to COVID-19
Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia
Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)